Skip to main content

Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human

Applications

Validated:

Western Blot, Inhibition of Cell Growth, Flow Cytometry, CyTOF-ready

Cited:

Western Blot, Neutralization, Flow Cytometry

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant human Lymphotoxin betaR/TNFRSF3
Ser28-Met227
Accession # P36941

Specificity

Detects human Lymphotoxin betaR/TNFRSF3 in direct ELISAs and Western blots.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Endotoxin Level

<0.10 EU per 1 μg of the antibody by the LAL method.

Scientific Data Images for Human Lymphotoxin  betaR/TNFRSF3 Antibody

Detection of Lymphotoxin  betaR/TNFRSF3 by Western Blot

Detection of Lymphotoxin betaR/TNFRSF3 by Western Blot

Blocking clathrin-dependent endocytosis enhances activation of canonical NF-kappa B signaling by LT betaR. A549 (a), HEK293T (b, d) and CCD1070Sk (c, d) cells were transfected with siRNAs targeting clathrin (CHC) (two oligonucleotides) along with control, non-targeting siRNAs (two oligonucleotides) or treated with chlorpromazine (CPZ, e-g) along with DMSO, and stimulated or not with Ago for 1 h. Lysates of cells were analyzed by Western blotting with antibodies against the indicated proteins. Graphs show densitometric analysis of abundance of I kappaB alpha, normalized to loading controls (GAPDH or vinculin). Values are presented as a fold change vs unstimulated non-targeting controls – averaged non-targeting controls (AvCtrl) or DMSO, set as 1. Data represent the means ± SEM, n = 3 (a, b, f, g), n = 4 (c, e); ns - P > 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001 by one sample t test. Tables present the fold change of I kappaB alpha abundance in stimulated vs unstimulated cells (means, n ≥ 3). d HEK293T and CCD1070Sk cells were analyzed with respect to the efficiency of clathrin knock-down. Representative blots are shown. The blots of GAPDH shown in panels b and c are also shown in panel d Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33148272), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Lymphotoxin  betaR/TNFRSF3 by Western Blot

Detection of Lymphotoxin betaR/TNFRSF3 by Western Blot

Clathrin and dynamin deficiency reduces activation of the non-canonical NF-kappa B pathway. a-c A549, HEK293T and CCD1070Sk cells were transfected with siRNAs targeting clathrin (CHC) (two oligonucleotides) along with control, non-targeting siRNAs (two oligonucleotides) and stimulated or not with Ago for 1 h. d, f A549 cells were transfected with siRNAs targeting dynamin-1/2 (three combinations of oligonucleotides targeting dynamin-1 and dynamin-2, see Methods) along with non-targeting control (Ctrl) siRNAs (two combinations of oligonucleotides, see Methods) and stimulated or not with Ago for 1 h. e, g A549 cells were treated with dynasore (DYN) or DMSO and stimulated or not with Ago for 1 h. Lysates of cells were analyzed by Western blotting with antibodies against the indicated proteins. Representative blots are shown. Values presented below blots represent the averaged p52/p100/loading control (a-e) or NIK/loading control ratio (f-g) from at least three experiments (normalized to the selected control, set as 1) in cells stimulated with Ago Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33148272), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Lymphotoxin  betaR/TNFRSF3 by Western Blot

Detection of Lymphotoxin betaR/TNFRSF3 by Western Blot

Blocking dynamin-dependent endocytosis enhances activation of canonical NF-kappa B signaling by LT betaR. A549 (a), HEK293T (b, d) and CCD1070Sk (c, d) cells were transfected with siRNAs targeting dynamin-1/2 (three combinations of oligonucleotides targeting dynamin-1 and dynamin-2, see Methods) along with non-targeting control (Ctrl) siRNAs (two combinations of oligonucleotides, see Methods) or treated with dynasore (DYN, e-g) along with DMSO, and stimulated or not with Ago for 1 h. Lysates of cells were analyzed by Western blotting with antibodies against the indicated proteins. Graphs show densitometric analysis of abundance of I kappaB alpha, normalized to loading controls (GAPDH or vinculin). Values are presented as a fold change vs unstimulated non-targeting controls – averaged non-targeting controls (AvCtrl) or DMSO, set as 1. Data represent the means ± SEM, n = 3 (b, c, f), n = 4 (a, e, g); ns - P > 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001 by one sample t test. Tables present the fold change of I kappaB alpha abundance in stimulated vs unstimulated cells (means, n ≥ 3). d HEK293T and CCD1070Sk cells were analyzed with respect to the efficiency of dynamin knock-down. Representative blots are shown Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33148272), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human Lymphotoxin  betaR/TNFRSF3 Antibody

Application
Recommended Usage

CyTOF-ready

Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.

Flow Cytometry

2.5 µg/106 cells
Sample: Human whole blood monocytes

Inhibition of Cell Growth

When immobilized at 50 µg/mL, this antibody will inhibit HT-29 human colon adenocarcinoma cell proliferation in the presence of 10 U/mL (1 ng/mL) Recombinant Human IFN-gamma (Catalog # 285-IF) by 2-4.5 fold.

Western Blot

0.1 µg/mL
Sample: Recombinant Human Lymphotoxin  betaR/TNFRSF3 Fc Chimera (Catalog # 629-LR)

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Lymphotoxin beta R/TNFRSF3

Lymphotoxin beta receptor (LT betaR), also known as TNF RIII and TNF R-related protein (TNF Rrp), was originally identified as a transcribed sequence on human chromosome 12p with homology to the TNF receptor superfamily. In the new TNF nomenclature, LT betaR is referred to as TNFRSF3. Human LT betaR cDNA encodes a 435 amino acid (aa) residue type I membrane protein with a putative 30 aa residue signal peptide, a 193 aa residue extracellular domain and a 171 aa residue cytoplasmic domain. The extracellular domain of LT betaR contains four cysteine-rich motif characteristic of the TNF receptor superfamily. The cytoplasmic region of LT betaR share little sequence similarity with other TNF receptor family members, suggesting that different signaling mechanisms may be utilized. LT betaR is expressed in a variety of tissues including visceral and lymphoid tissues. LT betaR is also expressed by cell lines of monocytic, epithelial, and fibroblastic origins but not by T and B lymphocytes. The human and mouse LT betaR share 76% aa sequence homology. The TNF family ligands that have been shown to bind and activate LT betaR include LIGHT (also a ligand for HVEM) and the heterotrimeric lymphotoxin LT alpha1/ beta2 or LT alpha2/ beta1. Depending on the cell type, activation of LT betaR has been shown to induce NF kappaB activation, chemokine production, growth arrest, and apoptosis. In vivo, LT betaR has been shown to play a critical role in controlling cellular immune functions and lymphoid organogenesis.

References

  1. Zhai, Y. et al. (1998) J. Clin. Invest. 102:1142.
  2. Rennert, P.D. et al. (1998) Immunity 9:71.
  3. Degli-Esposti, M.A. et al. (1997) J. Immunol 158:1756.
  4. Mackay, F. et al. (1996) J. Biol. Chem. 271:8618.
  5. Crowe, P.D. et al. (1994) Science 264:707.

Long Name

Lymphotoxin beta Receptor

Alternate Names

LTBR, LymphotoxinbR, TNF RIII, TNF Rrp, TNFRSF3

Entrez Gene IDs

4055 (Human); 17000 (Mouse); 297604 (Rat); 102135920 (Cynomolgus Monkey); 712550 (Rhesus Macaque)

Gene Symbol

LTBR

UniProt

Additional Lymphotoxin beta R/TNFRSF3 Products

Product Documents for Human Lymphotoxin  betaR/TNFRSF3 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human Lymphotoxin  betaR/TNFRSF3 Antibody

For research use only

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...